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Abstract Recently, normal individuals were identified who had 
high levels of plasma ¢x-galactosidase A activity and a G to A 
transition in the 5' untranslated (5' UT) region of the ol-galacto- 
sidase A gene. Electrophoretic mobility shift assays revealed that 
the wild-type sequence at the site of this mutation complexed with 
specific nuclear proteins. A standard NF-KB site competed with 
the 5' UT site for formation of these DNA-protein complexes. 
Complex formation was inhibited by the transition mutation. 
Therefore, the wild-type site might down-modulate expression of 
the o~-galactosidase A gene from this 5' untranslated region, 
which includes a previously described protein-binding site for 
another family of sequence-specific DNA-binding proteins, 
methylated DNA-binding protein. 
Key words: Transcription factor; ~-Galactosidase A; Promoter 
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I. Introduction 
those recognized by sequence-specific DNA-binding proteins 
involved in transcription control as well as a cluster of repeated 
10-bp sequences of unknown specificity [9]. Like many other 
housekeeping genes, this region is rich in CpG dinucleotides 
compared to the overall CpG content of mammalian DNA. 
During a recent screening of about 400 individuals, a G to 
A transition in the 5' untranslated (5' UT) region of the ot-GAL 
A gene was identified in several normal individuals who had 
plasma ~-Gal A activity levels that were 2- to 7-fold higher than 
the mean activity in random plasma samples [10]. The high- 
activity phenotype was inherited as an X-linked trait affecting 
only this lysosomal enzyme. No mutation other than this G to 
A transition was seen upon sequencing the full-length ot-GAL 
A cDNA, all eight intron-exon boundaries of the gene, and 
almost 200 bp of the upstream region from a high-activity 
variant. We report here that this mutation inhibited specific 
protein binding to the 5' UT sequence of the ~-GAL A gene and 
might, thereby, be responsible for the high activity level associ- 
ated with this variant allele. 
Human ~-galactosidase A (EC 3.2.1.22; ~-Gal A), a lyso- 
somal exoglycosidase, is encoded by a single X-linked 12-kb 
housekeeping ene, which has been cloned and sequenced 
along with the corresponding 5' flanking region and 1.4-kb 
cDNA [14]. This enzyme is present in a variety of human 
tissues [5] and a study of rats showed that its levels vary greatly 
from organ to organ [6]. A severe deficiency in ~-Gal A activity 
results in Fabry disease, a glycosphingolipid storage disorder. 
Many different mutations in the et-GAL A gene have been 
correlated with this disease, including partial gene deletions, 
insertions, and a variety of single-base substitutions affecting 
mRNA processing or translation [7,8]. 
The major transcription start point of the ct-GAL A gene is 
about 60 bp upstream of the starting codon [9]. Although the 
promoter region has not yet been dissected, the immediate 
upstream region of this gene contains everal motifs similar to 
2. Materials and methods 
2.1. Oligonucleotides 
Oligonucleotides were synthesized, lab led with [7-32p]ATE and an- 
nealed to form blunt-ended duplexes as described previously [11]. In 
addition to the oligonucleotides shown in Fig. 1, the following duplexes 
(written 5' to 3') were used, with only one strand of the sequence given 
and the MDBP or AP-2 sites in capital letters: EIAI, tttaGTTGCCTA- 
GCAACatga; Py2, ggcaGTTGCCTAGCAACtaat; Etp, tcatGTCTC- 
CATGGTAACttac (containing MDBP binding sites from the quine 
infectious anemia virus long terminal repeat, the polyomavirus en- 
hancer B, and the ets-2 promoter, espectively; see [12,13] and unpub- 
lished results) and Ap-2, gggagcaaagGCCTGGGGTgca (see [14] and 
unpublished results). 
2.2. Nuclear extracts 
Nuclear extracts were prepared as previously described [12] from 
HeLa or Raji cells grown in medium containing 10% fetal bovine serum 
except hat the HeLa cells, where indicated, had been treated with 5/zM 
forskolin and 100 ng/ml of phorbol 12-myristate 13-acetate (PMA) for 
1 h and then harvested. 
*Corresponding author. Department of Biochemistry/SL43, Tulane 
Medical School, 1430 Tulane Ave., New Orleans, LA 70112, USA. Fax: 
(1) (504) 584-2739. 
Abbreviations: ~-Gal A, a-galactosidase A; WT, wild-type; EMSA, 
electrophoretic mobility shift assay; kb, kilobase-pair; bp, base-pair; 5' 
UT, 5' untranslated; Lwt, specific protein binding site in the 5' UT 
region of the WT ot-GAL A gene; Lmu, mutant form of the Lwt site. 
2.3. EMSA 
Analysis of DNA-protein complex formation by electrophoretic mo- 
bility shift assay(s) (EMSA) was conducted as previously described with 
0.3-2/11 of nuclear extracts (~ 3 6 mg of protein per ml) pre-incubated 
with 1 ,ug of poly(dI-dC).poly(dI-dC), as a non-specific competitor, for 
10 min followed by a 15-min incubation at room temperature with 
2040 fmol of 32P-labeled ligand and then electrophoresis on a 5% 
polyacrylamide g l [15]. When a specific unlabeled oligonucleotide u- 
plex competitor was present (2 pmol unless otherwise noted), it was 
added 10 min before the radiolabeled ligand. Radiolabeled complexes 
were visualized upon autoradiography and quantitated by phosphori- 
mager analysis. 
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5 ' UT  (X "GAL A 5 ' -GGTTACCCGCGGAAATTTATGCTGTCCGGTCACCGTGACA~T~ ~ 3 ' 
Lwt  5 ' "GGTTACCCGCGGAAATTTATG - 3 ' 
Lmu 5 ' -GGTTACCCGCaGAAATTTATG-  3 ' 
NF -KB consensus  5 ' -GGGRNNYYCC-  3 ' 
KB  5 ' "GCCAATAGGGACTTTCCATT - 3 ' 
Fig. 1. Part of the 5' UT sequence of the ~-GAL A gene and related 
oligonucleotide uplexes. A region of the ot-GAL A gene immediately 
upstream of the initiation codon (doubly underlined) is shown (5' UT 
ct-GAL A) with the WT G residue that is mutated to an A in high- 
activity variants in italics and the previously demonstrated MDBP 
binding site [12] in boldface. The MDBP site is hown in its unmethyl- 
ated form although much more binding is seen to the CpG-methylated 
version of this site [12]. One strand of each of the following oligonucle- 
otide duplex ligands used for EMSA is also given: Lwt, the WT se- 
quence from this leading portion of the ~-GAL A gene; Lmu, the 
mutated form of this sequence found in several high-activity variants; 
and t¢B, a standard NF-xB ligand from the enhancer of the major 
immediate early gene of human cytomegalovirus [29]. The regions that 
match or are partially homologous to the NF-xB consensus sequence 
are underlined. The mutant base in Lmu is in lower case. 
3. Results 
3.1. A specific protein-binding site, Lwt, in the 5' untranslated 
region of  the ~-GAL A gene 
In order to test whether the c~-GAL A gene's G to A transi- 
tion, which was found in the gene's 5' UT region in four unre- 
lated high-activity variants [10], might affect binding of nuclear 
proteins, we assayed both the WT and mutant forms of this 
DNA sequence for specific complex formation with proteins in 
nuclear extracts. We noted that the WT form of the mutant 
sequence partially matches the NF-xB consensus equence 
(Fig. 1). Therefore, we compared as ligands in EMSA the fol- 
lowing three oligonucleotide duplexes: a consensus equence 
NF-xB site, xB duplex, and the WT and mutant forms of the 
leader egion's (5' UT) NF-xB-like oligonucleotide s quence in 
the et-GAL A gene, Lwt or Lmu duplexes, respectively (Fig. 1). 
As seen in Fig. 2, proteins in nuclear extracts from HeLa and 
Raji cells formed complexes with the Lwt oligonucleotide du- 
plex banding in the region of the complexes formed with the 
standard xB site. The mobility of these Lwt-protein complexes 
was greater than that of complexes containing a family of pro- 
teins (MDBP) that binds to a previously described protein- 
recognition site [12] in the 5' UT region of the ~-GAL A gene 
(Fig. 3, lane 1 vs. 3 and see below). Several unlabeled oligonu- 
cleotide duplex competitors were used in excess to try to com- 
pete with the radiolabeled Lwt duplex for formation of com- 
plexes with its cognate proteins in the HeLa nuclear extract. 
Formation of the specific radiolabeled Lwt-protein complexes 
was competed by the unlabeled xB duplex as well as by an 
excess of unlabeled Lwt duplex, but not appreciably by binding 
sites for MDBP or AP-2 (Fig. 3, lanes 3, 4, 6-9). Excess xB 
duplex also inhibited complex formation between radiolabeled 
Lwt duplex and proteins in a Raji nuclear extract while this 
complex formation decreased minimally with the addition of an 
irrelevant oligonucleotide duplex (Fig. 3B, lane 5). These find- 
ings indicate that specific proteins in mammalian uclear ex- 
tracts which recognize a standard NF-lcB ligand can complex 
with the Lwt duplex. 
3.2. Decreased protein binding to the Lmu site of  the high- 
activity variant allele 
An oligonucleotide uplex identical to the Lwt duplex except 
for the G to A transition at the Lwt site was used for EMSA 
with nuclear extracts. Much less specific complex formed with 
this radiolabeled uplex (Lmu, Fig. 1) than with the corre- 
sponding WT duplex (Lwt; Fig. 2A and B). The relative xtents 
of complex formation from Lmu vs. Lwt duplex with nuclear 
extracts of HeLa cells, induced HeLa cells (see below), and Raji 
cells were 0.2, 0.3, and 0.1, respectively. Furthermore, these 
ratios may be overestimates of the amount of specific complex 
formation by the Lmu duplex. Although the DNA protein 
complexes containing the Lmu duplex were seen in the general 
region of those containing the Lwt duplex, the patterns of 
bands were different (Fig. 2A, lanes 3 vs. 2, 6 vs. 5, 9 vs. 8). 
Competition experiments provided further evidence of the 
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Fig. 2. Recognition of the Lwt site from the ot-GAL A gene's 5' UT 
region by DNA-binding proteins in HeLa and Raji nuclear extracts as 
detected by EMSA. (A) 16-h exposure for autoradiography. (B) 3-h 
exposure of the same gel. EMSA was done with the indicated oligonu- 
cleotide duplex (Fig. 1) and an uninduced HeLa nuclear extract, a 
PMA- and forskolin-induced HeLa nuclear extract, or an uninduced 
Raji nuclear extract using 11, 7, and 8/zg, respectively, of protein. The 
specific activities of the xB, Lwt, and Lmu ligands were about 
4,200, 1500, and 2900 cpm/fmol, respectively, and 20 fmol of each 
ligand was used per assay. The three bands of specific complexes ob- 
tained with the xB duplex incubated with HeLa nuclear extracts are 
indicated in Panel B. 
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Fig. 3. Competition between various oligonucleotide duplexes for the binding of the Lwt site to proteins in nuclear extracts. (A) PMA- and 
forskolin-induced HeLa nuclear extract (7/lg of protein). (B) Raji nuclear extract (1 ,ug of protein). The sequences of the oligonucleotide duplexes 
used are given in Fig. 1 or section 2; Lwt is the WT NF-xB-like site in the 5' UT region of the ot-GAL A gene and EIA1 and Py2 are standard ligands 
for MDBP, which binds to a site neighboring the Lwt site in this 5' UT region (Fig. 1). Excess, unlabeled oligonucleotide duplex was added to the 
reaction mixture as competitor (see section 2). Below the displayed region of the autoradiogram was one other DNA-protein complex band but its 
formation was not competed by the addition of a y of the tested oligonucleotide duplexes, including an excess of the unlabeled form of the labeled 
ligand. The autoradiography exposure time for Panel B was about 1/5 the exposure time for Panel A. 
lower affinity of the Lmu duplex vs. the analogous WT duplex 
for specific complex formation. When excess unlabeled Lmu 
duplex was used as a competitor in the binding reaction f
radiolabeled Lwt duplex and HeLa nuclear extract proteins, 
less inhibition of formation of radiolabeled complex was seen 
than when the same excess of unlabeled Lwt duplex was added 
(Fig. 3A, lanes 3-5). 
3.3. Comparison of the nuclear proteins binding to the Lwt site 
and the major NF-KB family proteins in HeLa or Raji 
nuclear extracts 
Complex formation between the Lwt duplex and nuclear 
proteins was compared for nuclear extracts from HeLa cells 
grown in normal medium (uninduced extracts) and in medium 
supplemented with PMA and forskolin (induced extracts). 
Upon EMSA, the ratio of total radioactivity in specific bands 
from induced vs. uninduced extracts was 3.4 for the KB duplex; 
however, the analogous ratio for the Lwt duplex was 1.0 (Fig. 
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Fig. 4. The Lwt site from the o~-GAL A 5' UT region only partially 
competes with a standard NF-xB site for complex formation with 
nuclear proteins. (A) PMA- and forskolin-induced HeLa nuclear ex- 
tract. (B) Raji nuclear extract. Competition assays were conducted as 
for Fig. 3 except that the exposure times for Panels A and B were 
approximately the same. 
extract han with the induced or uninduced HeLa nuclear ex- 
tracts when either the xB duplex or the Lwt duplex was the 
ligand (Fig. 2B). 
Although the complexes formed between either the Lwt or 
xB duplexes and cognate proteins i  HeLa or Raji nuclear 
extracts had similar electrophoretic mobilities, the patterns of 
specific bands upon electrophoresis were different. In nuclear 
extracts from uninduced or PMA- and forskolin-induced HeLa 
cells, a higher-mobility band (c, Fig. 2B, lanes 1 and 4) predom- 
inated over two lower-mobility bands (a and b) when the KB 
duplex was the ligand. With the Lwt ligand, only the a and c 
bands were seen and the ratio of intensities of these bands was 
1.0 (Fig. 2A, lanes 2 vs. 1 and 5 vs. 4). Also, with Raji nuclear 
extracts, ligand-specific differences were seen; the leading edge 
of the band of DNA protein complexes was lower in the gel 
for the KB ligand than for the Lwt duplex (Fig. 2B, lanes 7 vs. 
8 and Fig. 3B, lanes 1 vs. 5). 
As noted above, excess unlabeled KB duplex was a good 
competitor for the formation of all the specific DNA-protein 
complexes containing radiolabeled Lwt duplex; however, the 
converse was not true. With the nuclear extract from induced 
HeLa cells and the 32p-labeled KB duplex as the ligand, 2 pmol 
of unlabeled Lwt duplex as the competitor decreased specific, 
labeled complex formation by only 38% (Fig. 4A, lanes 3 vs. 
1). In the same experiment, the formation of labeled NF-KB- 
like complexes with the DNA ligands was decreased by 96% 
and 6% by the addition of 2 pmol of unlabeled I¢Band Lmu 
duplexes, respectively (Fig. 4A, lanes 2 and 4 vs. 1). Similarly, 
with a nuclear extract from Raji cells and radiolabeled KB 
duplex, 2 pmol of the unlabeled Lwt duplex competed for 
specific DNA-protein complex formation less efficiently than 
2 pmol of unlabeled xB duplex but more effectively than the 
same amount of unlabeled Lmu duplex. The formation of the 
slower moving complexes was inhibited more than that of the 
faster moving complexes (Fig. 4B). Increasing the amount of 
unlabeled Lwt competitor to 5 pmol did not further decrease 
the formation of specific DNA-protein complexes between la- 
beled xB duplex and NF-xB family proteins in the Raji nuclear 
extract (data not shown). 
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4. Discussion 
The studies described here demonstrate hat specific DNA- 
protein complexes are formed between proteins in nuclear ex- 
tracts from Raji or HeLa cells and a sequence, designated Lwt, 
containing an NF-xB-like site from the 5' UT region of the WT 
~-GAL A gene. The Lwt site deviates from the NF-xB consen- 
sus sequence by 3 bp and has a central 6-bp palindrome (Fig. 
1). DNA-protein complexes containing this oligonucleotide 
duplex electrophoresed in the same region of the gel as those 
containing a standard NF-xB site (xB duplex, Fig. 1); however, 
ligand-dependent differences in the pattern of the DNA-pro- 
tein bands were seen (Fig. 2). Also, when the Lwt duplex was 
used in excess to compete for formation of complexes between 
the xB duplex and NF-xB proteins in HeLa or Raji nuclear 
extracts, specific competition was seen but it was only partial 
(Fig. 4). In the converse xperiment, the xB duplex competed 
efficiently for the formation f Lwt-protein complexes (Fig. 3). 
The Lwt-binding activity, unlike the xB duplex-binding activity 
in HeLa cells [16], was not inducible after a brief treatment with 
PMA in the presence of forskolin (Fig. 2). Therefore, the major 
form of NF-xB in induced HeLa nuclear xtracts, p50/p65 
[17,18], is not the predominant protein that bound to the Lwt 
sequence in the ct-GAL A 5' UT region. Not all NF-xB-type 
proteins accumulate appreciably inthe nucleus upon induction, 
even in HeLa cells [19], and different NF-xB proteins can differ 
somewhat in their preferences for DNA sequences related to 
the NF-lcB consensus sequence [20,21]. Therefore, other mem- 
bers of the NF-xB family, such as c-Rel-containing forms of 
NF-tcB, which are the predominant type of NF-xB in B cell 
lines like Raji [17,18], might be binding to the Lwt site. Because 
two distinct Lwt-specific bands were seen in EMSA with HeLa 
nuclear extracts (Fig. 2A) and a cluster of bands were seen with 
Raji nuclear extracts (Fig. 2B), there may be more than one 
specific Lwt-binding protein. 
The Lwt site in the c~-GAL A gene's 5' UT region identified 
in the present study is the location of a G to A transition 
recently found in six individuals displaying high plasma levels 
of ct-Gal A activity [10]. This mutant sequence (Lmu; Fig. 1) 
complexed to a much lesser extent with t e Lwt-specific binding 
activity than did the Lwt site (Figs. 2 and 3). For one of these 
individuals, the entire coding region and about 200 bp of the 
upstream region of the ~-GAL A gene were sequenced [10]. 
Only this G to A transition in the 5' UT region was seen. This 
mutation did not inhibit in vitro translation of the correspond- 
ing c~-GA L A mRNA in a rabbit reticulocyte ranslation system 
using recombinant plasmid-encoded mRNA [10]. 
We propose that, in addition to the cap-upstream promoter, 
this 5' UT gene region is important in transcription control via 
the binding of sequence-specific transcription factors as seen 
for some other Class II genes (e.g. [22,23]). The mutation asso- 
ciated with the high-activity c~-Gal A phenotype is 19 bp up- 
stream of a site that was shown to bind to a family of sequence- 
specific DNA-binding proteins called methylated DNA binding 
protein (MDBP; 12). For many, but not all, MDBP sites, in- 
cluding the ~-GAL A site, binding is much better when the site 
is methylated atits CPG dinucleotides. Much evidence indicates 
that DNA methylation is involved in negatively controlling 
expression of many genes in mammals, including X-linked 
genes subject o lyonization [24,25]. MDBP sites have been 
implicated in the negative control of gene expression from cer- 
tain sites as well as in positive control from others [26-28]. The 
5' UT region of the ~-GAL A gene might be involved in down- 
modulation of gene expression from both the Lwt and MDBP 
sites, functioning either independently or co-operatively. Muta- 
tion of the Lwt site to a weaker binding site for an Lwt-specific 
DNA-binding protein could thereby increase the level of ex- 
pression of the c~-GAL A gene. 
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